STRATEGIC INVESTMENT PERSPECTIVES IN THE EVOLVING EUROPEAN AND GLOBAL ATMP LANDSCAPE

This panel will aim to offer a comprehensive exploration of the present investment landscape within the ATMP sector. Attendees will gain insights into the current state of investments and witness a dynamic discussion on how investors are strategically adjusting to the ever-changing financial terrain. This session will provide valuable perspectives on navigating challenges and seizing opportunities within this rapidly evolving investment ecosystem.
Moderator:
Phil Vanek, Ph.D., Partner and Chief Technology Officer, Gamma Biosciences
Speakers:
Lucia Faccio, Ph.D., Partner, Sofinnova Partners
Sven Kili, Investment Advisor, Saisei Ventures
Philipp Pletnev, Ph.D., Senior Analyst, Biovision Ventures
Bo Wiinberg, Ph.D., Chief Business Development Officer, Novo Nordisk Foundation Cellerator